Eli Lilly

Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Flag link:
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Axsome Therapeutics
AXS-05
treatment-resistant depression
depression
Eli Lilly
pegilodecakin
lung cancer
Flag link:
Leukemia rivals try to stay ahead as Merck, Lilly chase
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
Flag link:
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Eli Lilly
Loxo Oncology
ASH2019
CLL
Flag link:
Lilly puts its cancer future in Loxo's hands
Lilly puts its cancer future in Loxo's hands
Biopharma Dive
Eli Lilly
Loxo Oncology
M&A
cancer
R&D
oncology
Flag link:
Lilly putting $400M into U.S. diabetes production, adding 100 jobs
Lilly putting $400M into U.S. diabetes production, adding 100 jobs
Fierce Pharma
Eli Lilly
diabetes
drug manufacturing
hirings
Flag link:
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
Flag link:
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Flag link:
Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy
Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy
Endpoints
myotonic muscular dystrophy
Eli Lilly
R&D
Avidity
Flag link:
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Flag link:
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data
Fierce Pharma
Eli Lilly
Taltz
psoriatic arthritis
AbbVie
Humira
Flag link:
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes
Flag link:
Dogs help Eli Lilly scientists identify new osteoarthritis target
Dogs help Eli Lilly scientists identify new osteoarthritis target
Fierce Biotech
osteoarthritis
Eli Lilly
drug discovery
R&D
osteoarthritis in dogs
Flag link:
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
Flag link:
Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data
Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data
Bloomberg
Eli Lilly
Biogen
Alzheimer's disease
David Ricks
Flag link:
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Lilly USA diabetes chief Enrique Conterno bows out after 27 years
Fierce Pharma
Eli Lilly
diabetes
Enrique Conterno
Flag link:
Eli Lilly (LLY) Surpasses Q3 Earnings Estimates
Eli Lilly (LLY) Surpasses Q3 Earnings Estimates
Yahoo/Zacks.com
Eli Lilly
earnings
Flag link:
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
Flag link:
Lilly cancer drug pipeline hit by trial setback
Lilly cancer drug pipeline hit by trial setback
Biopharma Dive
Eli Lilly
pegilodecakin
immunotherapy
pancreatic cancer
ARMO BioSciences
Flag link:
Eli Lilly to shutter neuroscience R&D center next year
Eli Lilly to shutter neuroscience R&D center next year
Fierce Biotech
Eli Lilly
UK
layoffs
R&D
Flag link:

Pages